Provided by Tiger Fintech (Singapore) Pte. Ltd.

EyePoint

11.43
+0.41503.77%
Volume:528.76K
Turnover:5.97M
Market Cap:922.58M
PE:-4.22
High:11.75
Open:10.96
Low:10.86
Close:11.02
52wk High:14.91
52wk Low:3.91
Shares:80.72M
Float Shares:54.46M
Volume Ratio:0.51
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7110
EPS(LYR):-2.3246
ROE:-73.95%
ROA:-37.79%
PB:3.75
PE(LYR):-4.92

Loading ...

Stock Track | EyePoint Pharmaceuticals Soars 5.49% as RBC Boosts Price Target Amid Clinical Progress

Stock Track
·
1 hour ago

EyePoint Pharmaceuticals Is Maintained at Outperform by RBC Capital

Dow Jones
·
1 hour ago

RBC Raises Price Target on EyePoint Pharmaceuticals to $39 From $28, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Yesterday

EyePoint Pharma Advances DURAVYU in Retinal Disease Trials

TIPRANKS
·
Yesterday

EyePoint Pharmaceuticals (EYPT): Persistent Losses Challenge Bullish Revenue Growth Narrative

Simply Wall St.
·
Yesterday

EyePoint Pharmaceuticals Q3 2025 Earnings Call Summary and Q&A Highlights: DuraVu Phase 3 Trials and Financial Performance

Earnings Call
·
Yesterday

EyePoint (EYPT) Q3 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Yesterday

EyePoint Pharmaceuticals (EYPT) Gets a Buy from Mizuho Securities

TIPRANKS
·
Yesterday

Stock Track | EyePoint Pharmaceuticals Plummets 9.04% Following Disappointing Q3 Results and Wider Losses

Stock Track
·
Nov 05

Stock Track | EyePoint Pharmaceuticals Plunges 7% Pre-Market on Wider Q3 Loss and Revenue Miss

Stock Track
·
Nov 05

Stock Track | EyePoint Pharmaceuticals Plunges 7.02% Pre-market on Disappointing Q3 Results

Stock Track
·
Nov 05

EyePoint Pharmaceuticals Q3 EPS $(0.85) Misses $(0.79) Estimate, Sales $966.000K Miss $3.329M Estimate

Benzinga
·
Nov 05

EyePoint Pharmaceuticals Q3 Operating Expenses USD 62.991 Million

THOMSON REUTERS
·
Nov 05

EyePoint Pharmaceuticals Q3 Product Sales USD 582 Thousand

THOMSON REUTERS
·
Nov 05

EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments

GlobeNewswire
·
Nov 05

EyePoint Announces Participation at Upcoming Investor Conferences

GlobeNewswire
·
Nov 03

EyePoint Pharmaceuticals (EYPT) Gets a Buy from Mizuho Securities

TIPRANKS
·
Oct 17

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Oct 16

BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, First Horizon, 60 Degrees

Reuters
·
Oct 15

BUZZ-U.S. STOCKS ON THE MOVE-AMD, Bank of America, Morgan Stanley

Reuters
·
Oct 15